D. E. Shaw & Co »

Edgewise Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.6M 474k 18.24
2023-12-31 $350k 32k 10.94
2023-03-31 $165k 25k 6.67
2022-12-31 $101k 11k 8.94
2021-09-30 $227k 14k 16.58
2021-06-30 $985k 46k 21.34

More positions owned by D. E. Shaw & Co

Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
Netflix Put Option (NFLX)
Chipotle Mexican Grill (CMG)
Uber Technologies Put Option (UBER)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Visa Com Cl A (V)
Booking Holdings (BKNG)
Pfizer Put Option (PFE)
Advanced Micro Devices Put Option (AMD)
Citigroup Com New (C)

View all positions for D. E. Shaw & Co

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
FMR
Baker Bros. Advisors
BlackRock
Vanguard Group
Viking Global Investors
Frazier Life Sciences Management
Cormorant Asset Management
Deerfield Management Company
Citadel Advisors
Paradigm Biocapital Advisors
Perceptive Advisors
VR Adviser
Henderson Group

View all funds holding Edgewise Therapeutics